Source:http://linkedlifedata.com/resource/pubmed/id/16505203
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-3-24
|
pubmed:abstractText |
Many effects believed to be because of angiotensin II (Ang II) are attributable to the action of endothelin (ET)-1, which is released/produced by Ang II. We investigated whether Ang II elicits its positive inotropic effect (PIE) by the action of endogenous ET-1, in addition to the role played by reactive oxygen species (ROS) in this mechanism. Cat cardiomyocytes were used for: (1) sarcomere shortening measurements; (2) ROS measurements by epifluorescence; (3) immunohistochemical staining for preproET-1, BigET-1, and ET-1; and (4) measurement of preproET-1 mRNA by RT-PCR. Cells were exposed to 1 nmol/L Ang II for 15 minutes. This low concentration of Ang II increases sarcomere shortening by 29.2+/-3.7% (P<0.05). This PIE was abrogated by Na+/H+ exchanger or Na+/Ca2+ exchanger reverse mode inhibition. The production of ROS increased in response to Ang II treatment (DeltaROS respect to control: 68+/-15 fluorescence units; P<0.05). The Ang II-induced PIE and ROS production were blocked by the Ang II type 1 receptor blocker losartan, the nonselective ET-1 receptor blocker TAK044, the selective ETA receptor blocker BQ-123, or the ROS scavenger N-(2-mercapto-propionyl)glycine. Exogenous ET-1 (0.4 nmol/L) induced a similar PIE and increase in ROS production to those caused by Ang II. Immunostaining for preproET-1, BigET-1, and ET-1 was positive in cardiomyocytes. The preproET-1 mRNA abundance increased from 100+/-4.6% in control to 241.9+/-39.9% in Ang II-treated cells (P<0.05). We conclude that the PIE after exposure to 1 nmol/L Ang II is due to endogenous ET-1 acting through the ETA receptor and triggering ROS production, Na+/H+ exchanger stimulation, and Na+/Ca2+ exchanger reverse mode activation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Endothelin A,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Hydrogen Antiporter
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1524-4563
|
pubmed:author |
pubmed-author:AielloErnesto AEA,
pubmed-author:Camiliónde HurtadoMaría CMC,
pubmed-author:CingolaniHoracio EHE,
pubmed-author:CornelliMarianaM,
pubmed-author:CorreaMaría VMV,
pubmed-author:EnnisIrene LIL,
pubmed-author:GarciarenaCarolinaC,
pubmed-author:NollyAlejandroA,
pubmed-author:SuburoAngela MAM,
pubmed-author:TorbidoniVanesaV,
pubmed-author:Villa-AbrilleMaría CMC
|
pubmed:issnType |
Electronic
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
727-34
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16505203-Angiotensin II,
pubmed-meshheading:16505203-Animals,
pubmed-meshheading:16505203-Cardiotonic Agents,
pubmed-meshheading:16505203-Cats,
pubmed-meshheading:16505203-Endothelin-1,
pubmed-meshheading:16505203-Immunohistochemistry,
pubmed-meshheading:16505203-Myocardial Contraction,
pubmed-meshheading:16505203-Myocytes, Cardiac,
pubmed-meshheading:16505203-Reactive Oxygen Species,
pubmed-meshheading:16505203-Receptor, Endothelin A,
pubmed-meshheading:16505203-Sarcomeres,
pubmed-meshheading:16505203-Sodium-Hydrogen Antiporter,
pubmed-meshheading:16505203-Staining and Labeling
|
pubmed:year |
2006
|
pubmed:articleTitle |
The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species.
|
pubmed:affiliation |
Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina. cimes@infovia.com.ar
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|